CNTB SCHEDULE 13G/A: SEC filing

Ikarian Capital, LLC and Neil Shahrestani

Filed with the SEC on · accession 0001778253-26-000007

CNTB filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -5.1% by the first close after the filing.

Summary of the filing

Ikarian Capital, LLC and Neil Shahrestani filed an amended Schedule 13G reporting beneficial ownership of 2,163,352 ordinary shares, or 3.4%, of Connect Biopharma Holdings Ltd as of September 30, 2026.

Key details

Ordinary shares beneficially owned$2.2M
Percent of class ownedPCT 3
Reporting person / investment adviserIkarian Capital, LLC
IssuerConnect Biopharma Holdings Ltd
Record owner of sharesIkarian Healthcare Master Fund, L.P.
Sole manager of ikarian capital, llcNeil Shahrestani

How CNTB stock reacted

Close before

$0.68

Nov 13, 2026

First close after

-5.05%

$0.64

5 trading days

—

Since filing

-14.53%

$0.58

✦ Ask GOAX AI about this filing — what it means for CNTB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CNTB?

Click here

Frequently asked questions

What did CNTB file with the SEC on Nov 16, 2026?

CNTB filed a SCHEDULE 13G/A (SEC filing). Ikarian Capital, LLC and Neil Shahrestani filed an amended Schedule 13G reporting beneficial ownership of 2,163,352 ordinary shares, or 3.4%, of Connect Biopharma Holdings Ltd as of September 30, 2026.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did CNTB stock react to this filing?

CNTB closed at $0.68 before the filing and $0.64 on Nov 16, 2026 (-5.05%).

Other CNTB SEC filings

Get alerts when CNTB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days